Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
Sanara MedTech Inc.

Sanara MedTech Inc. (SMTI) Stock Overview

Explore Sanara MedTech Inc.’s financial performance, market position, analyst ratings, and future outlook.

SMTI●NASDAQ
HealthcareMedical - Instruments & Supplies
$34.45
$0.21(0.61%)
U.S. Market opens in 64h 56m

Sanara MedTech Inc. (SMTI)

Meyka AI Score

Z

Key Financials

Market Cap316.7M
P/E Ratio-9.21
EPS (TTM)$-0.06
ROE-4.74%
Fundamental Analysis

AI Price Forecasts

1 Month$41.16
3 Months$19.78
1 Year Target$24.45

SMTI Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of Sanara MedTech Inc. (NASDAQ: SMTI) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Sanara MedTech Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of SMTI on the NASDAQ shows an RSI of 79.57, suggesting the stock is in a an overbought condition. Our forecasting models predict a 12-month price target of $24.45 for the NASDAQ listing.

Key metrics behind Sanara MedTech Inc.'s NASDAQ-traded stock include a P/E ratio of -9.21 and a market capitalization of 316.7M. Combined with our AI analysis, these give both institutional and retail investors a clear view of SMTI on the NASDAQ.

Price Performance (NASDAQ: SMTI)

1-Day Change
0.61%
5-Day Change
1.03%
1-Month Change
35.10%
3-Month Change
45.73%
6-Month Change
68.46%
Year-to-Date (YTD) Change
47.54%
1-Year Change
12.88%
3-Year Change
-11.69%
5-Year Change
2.84%
All-Time (Max) Change
-88.52%

Contact Information

https://sanaramedtech.com
817 529 2300
1200 Summit Avenue, Fort Worth, TX, 76102

Company Facts

1,080 Employees
IPO DateApr 7, 1994
CountryUS
Actively Trading

Frequently Asked Questions